Acorah Software Products - Accounts Production 16.7.461 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 04827501 Mr Oscar D'Agnone Miss Alicia Trabado iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 04827501 2024-03-31 04827501 2025-03-31 04827501 2024-04-01 2025-03-31 04827501 frs-core:CurrentFinancialInstruments 2025-03-31 04827501 frs-core:FurnitureFittings 2025-03-31 04827501 frs-core:FurnitureFittings 2024-04-01 2025-03-31 04827501 frs-core:FurnitureFittings 2024-03-31 04827501 frs-core:PlantMachinery 2025-03-31 04827501 frs-core:PlantMachinery 2024-04-01 2025-03-31 04827501 frs-core:PlantMachinery 2024-03-31 04827501 frs-core:ShareCapital 2025-03-31 04827501 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 04827501 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04827501 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 04827501 frs-bus:SmallEntities 2024-04-01 2025-03-31 04827501 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 04827501 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 04827501 frs-core:ListedExchangeTraded 2025-03-31 04827501 frs-core:ListedExchangeTraded 2024-03-31 04827501 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-03-31 04827501 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-03-31 04827501 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-03-31 04827501 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-03-31 04827501 frs-bus:Director1 2024-04-01 2025-03-31 04827501 frs-bus:Director2 2024-04-01 2025-03-31 04827501 frs-bus:Director2 2024-03-31 04827501 frs-bus:Director2 2025-03-31 04827501 frs-countries:EnglandWales 2024-04-01 2025-03-31 04827501 2023-03-31 04827501 2024-03-31 04827501 2023-04-01 2024-03-31 04827501 frs-core:CurrentFinancialInstruments 2024-03-31 04827501 frs-core:ShareCapital 2024-03-31 04827501 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 04827501
Seagrave Healthcare Limited
Unaudited Financial Statements
For The Year Ended 31 March 2025
Taylor, Robertson & Willet Ltd
95 King Street
Lancaster
Lancashire
LA1 1RH
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 04827501
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 2,903 4,964
Investments 5 135,675 135,675
138,578 140,639
CURRENT ASSETS
Debtors 6 46,101 365,834
Cash at bank and in hand 220,239 1,421,311
266,340 1,787,145
Creditors: Amounts Falling Due Within One Year 7 (305,040 ) (289,055 )
NET CURRENT ASSETS (LIABILITIES) (38,700 ) 1,498,090
TOTAL ASSETS LESS CURRENT LIABILITIES 99,878 1,638,729
NET ASSETS 99,878 1,638,729
CAPITAL AND RESERVES
Called up share capital 8 10,000 10,000
Profit and Loss Account 89,878 1,628,729
SHAREHOLDERS' FUNDS 99,878 1,638,729
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Miss Alicia Trabado
Director
31/12/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Seagrave Healthcare Limited is a private company, limited by shares, incorporated in England & Wales, registered number 04827501 . The registered office is 25a Eccleston Street , London, SW1W 9NP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 20% on cost
Fixtures & Fittings 20% on cost
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 6 (2024: 8)
6 8
4. Tangible Assets
Plant & Machinery Fixtures & Fittings Total
£ £ £
Cost
As at 1 April 2024 - 66,112 66,112
Additions 587 - 587
As at 31 March 2025 587 66,112 66,699
Depreciation
As at 1 April 2024 - 61,148 61,148
Provided during the period 118 2,530 2,648
As at 31 March 2025 118 63,678 63,796
Net Book Value
As at 31 March 2025 469 2,434 2,903
As at 1 April 2024 - 4,964 4,964
5. Investments
Listed
£
Cost or Valuation
As at 1 April 2024 135,675
As at 31 March 2025 135,675
Provision
As at 1 April 2024 -
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 135,675
As at 1 April 2024 135,675
Investment in subsidiary company 
6. Debtors
2025 2024
£ £
Due within one year
Trade debtors 5,967 23,341
Other debtors 40,134 342,493
46,101 365,834
Page 4
Page 5
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 1,160 (1 )
Other creditors 100,976 134,458
Taxation and social security 202,904 154,598
305,040 289,055
8. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 10,000 10,000
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 April 2024 Amounts advanced Amounts repaid Amounts written off As at 31 March 2025
£ £ £ £ £
Mr Oscar D'Agnone 285,624 - - - -
The loan was made on an interest free basis.
Dividends totalling £160,000 (2023 - £160,000) were paid in the year in respect of shares held by the company's directors.
Page 5